Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...

(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...

Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's board needs to hold ...

纽约 - 以参与上市公司著称的投资公司Starboard Value LP最近在2024年主动-被动投资者峰会上介绍了其提升股东价值的策略。该公司首席执行官兼首席投资官Jeffrey Smith展示了Kenvue Inc. (NYSE: ...

10月22，据外媒报道，辉瑞大股东Starboard Value（激进/维权投资者）首席执行官Jeffrey Smith在2024主动-被动投资者峰会发表演讲时对辉瑞过去5年在二级市场的表现提出质疑，并认为辉瑞的高管并未履行“持续不断地进行突破性创新 ...

Despite that cash windfall, Pfizer has "dramatically underperformed its peers and the market since 2019," according to ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

格隆汇10月23日｜活跃投资公司Starboard Value首席执行官兼投资总监Jeffrey ...

By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...

知情人士透露，对冲基金Starboard Value已入股消费品公司Kenvue，后者于去年上市，前身为强生公司消费者健康业务，公司旗下品牌包括露得清、邦迪、泰诺等。Kenvue的代表尚未就此发表评论。（路透） ...

继54亿美元并购而来的镰刀型细胞病（SCD）药物Oxbryta从全球市场撤回，5.25亿美元引进的口服RSV疗法打水漂后，有些“水逆”的辉瑞迎来潜在转折性一刻：华尔街知名的激进投资者/维权投资基金Starboard ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...